Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
12 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2021-09-02 | 2021-12-01 | 145115 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-09-23 | 2021-11-18 | 146112 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146449 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146456 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-10-07 | 2021-11-11 | 146847 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2021-10-14 | 2021-12-17 | 147216 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2021-10-21 | 2021-12-08 | 147705 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151419 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-02-24 | 2022-04-01 | 155557 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-03-24 | 2022-03-26 | 157274 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-06-03 | 2022-08-19 | 161949 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-08-18 | 2022-10-18 | 167153 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-10-17 | 2023-01-12 | 172013 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-10-28 | 2023-01-12 | 173061 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-11-14 | 2023-01-12 | 174586 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-11-14 | 2023-04-28 | 174589 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177508 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177511 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-02-02 | 177514 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177517 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LORAZEPAM | 1MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258513 |
| TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133896 |
| TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133899 |
| TEVA-LOSARTAN/HCTZ | 50.0MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133902 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256113 |
| TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256116 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256119 |
| TEVA-METFORMIN | 850MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258449 |
| TEVA-METFORMIN | 500MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258452 |
| TEVA-METOPROLOL | 50MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119976 |
| TEVA-METOPROLOL | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258537 |
| TEVA-METOPROLOL | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258568 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133908 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240081 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253165 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258532 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258535 |
| TEVA-MODAFINIL | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258732 |
| TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
| TEVA-NAPROXEN | 375MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258493 |